In March 2025, the company announced new designs for just a direct-to-consumer featuring of its Wegovy weight loss drug. The company proven a brand new pharmacy, named NovoCare, which would cost customers $499 per 30 days for access to the drug, less than 50 percent the expense of the drug through other pharmaceutical distribution networks.[fifty t